Kester secures a second investment from Fund IV, led by Databalance SBO. The firm’s existing shareholder, 5CS Capital Partners, continues to participate in the funding round. The announcement highlights ongoing confidence in Kester’s growth strategy and operational expansion.
The Private Equity Awards 2026 recognize leading firms and individuals in private equity. Winners span categories including deal execution, fund performance, and innovation. Judges highlight standout contributions in portfolio company growth and industry leadership.
Kester Capital is investing in **Nutritics**, a provider of nutrition analysis software. **DC Advisory** serves as the exclusive financial advisor for this transaction, facilitating the deal between the investor and the company.
Kester finalizes its £425m Fund IV at hard-cap capacity after a four-month, oversubscribed raise. Institutional investors—both existing and new—drived demand, enabling a single close without further extensions. The fund marks the firm’s fourth capital vehicle, targeting private equity investments.
Nov 2025Private Equity WireNews article
Kester Capital
Kester Capital, a leading UK mid-market private equity firm, specializes in primary buy-outs with investments of £5-25 million.
